key: cord-1044251-5t1g55ir authors: Prentice, Ralley E.; Al‐Ani, Aysha H.; Christensen, Britt title: Letter: Covid‐19—re‐initiating clinical services for chronic gastrointestinal diseases. How and when? Authors' reply date: 2020-09-20 journal: Aliment Pharmacol Ther DOI: 10.1111/apt.16065 sha: af9c76088f86ff55dbada155db842d5e003f5ce4 doc_id: 1044251 cord_uid: 5t1g55ir LINKED CONTENT This article is linked to Al‐Ani et al and Britton et al papers. To view these articles, visit https://doi.org/10.1111/apt.15779 and https://doi.org/10.1111/apt.16061 We thank Britton et al for their considered letter 1 to our recently published review of prevention and management of Covid-19 in inflammatory bowel disease (IBD) patients. 2 We commend their survey evaluating adherence with social distancing and shielding recommendations in addition to patient preferences for method of out-patient review among 195 patients with high-risk chronic gastroenterological conditions, including 33 with IBD. 1 In the re-initiation phase of the pandemic, we aim to re-commence services in a tailored manner taking into consideration the current evidence for the role of telemedicine in IBD care. The management of IBD patients from remote locations is clearly established as being safe, acceptable to patients, cost-effective and convenient. 3, 4 Additionally, electronic home monitoring tools for patients with IBD are feasible and highly accepted. 5 Overall, the use of electronic health (eHealth) technologies in IBD is associated with improved medication adherence, quality of life, and IBD-related knowledge, with reduced duration of disease relapse and activity. 6 The Covid-19 pandemic has effectively forced healthcare systems, practitioners and patients to adopt these tools as a means of minimising healthcare-related patient exposures, 7 Letter: COVID-19 -re-initiating clinical services for chronic gastrointestinal diseases. How and when? Review article: prevention, diagnosis and management of COVID-19 in the IBD patient Videoconference clinics improve efficiency of inflammatory bowel disease care in a remote and rural setting Integration of telemedicine into clinical gastroenterology and hepatology practice Development and feasibility study of a telemedicine tool for all patients with IBD: MyIBDcoach EHealth technologies in inflammatory bowel disease: a systematic review Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty Telehealth in the context of COVID-19: changing perspectives in Australia, the United Kingdom, and the United States Addressing equity in telemedicine for chronic disease management during the Covid-19 pandemic Inflammatory bowel disease in the COVID-19 pandemic: the patients' perspective